Indoleamine 2,3-dioxygenase (IDO) is an enzyme that facilitates the metabolism of tryptophan (Trp) and is controlled in the glioblastoma microenvironment to suppress immune activity. This evidence concerns the gene IDO1 and glioblastoma.